Conshohocken-based AmerisourceBergen, a global healthcare company, recently launched its Cell and Gene Therapy (CGT) Integration Hub.
The hub, powered by AmerisourceBergen’s innovative customer relationship management system, can be integrated with biopharma or provider-facing platforms for real-time data exchange and to help arrange services.
“Cell and gene therapies offer tremendous promise, but the unique characteristics of these treatments – coupled with the urgency with which they need to be delivered – requires flawless execution and heightened coordination from the moment a patient is identified all the way through the treatment administration,” Dale Hanna, AmerisourceBergen director of cell and gene therapy solutions, said. “Through the CGT Integration Hub, our goal is to increase connectivity and reduce potential barriers across the patient journey, simplifying the care coordination process and enabling an enhanced patient and provider experience.”
The hub can expedite the benefits investigation process, so providers receive a response on a patient’s coverage determination after they enter patient enrollment information; provide physicians and case managers with real-time therapy development and transportation status to coordinate patient scheduling; and alert case managers of any status changes, so they can reach out to patients and caregivers if needed.
AmerisourceBergen employs more than 44,000 people worldwide and has more than $200 billion in annual revenue.